JPH11193282A5 - - Google Patents

Info

Publication number
JPH11193282A5
JPH11193282A5 JP1997367887A JP36788797A JPH11193282A5 JP H11193282 A5 JPH11193282 A5 JP H11193282A5 JP 1997367887 A JP1997367887 A JP 1997367887A JP 36788797 A JP36788797 A JP 36788797A JP H11193282 A5 JPH11193282 A5 JP H11193282A5
Authority
JP
Japan
Prior art keywords
group
substituted
aroyl
alkyl
alkanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997367887A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11193282A (ja
JP4189048B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP36788797A priority Critical patent/JP4189048B2/ja
Priority claimed from JP36788797A external-priority patent/JP4189048B2/ja
Publication of JPH11193282A publication Critical patent/JPH11193282A/ja
Publication of JPH11193282A5 publication Critical patent/JPH11193282A5/ja
Application granted granted Critical
Publication of JP4189048B2 publication Critical patent/JP4189048B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP36788797A 1997-12-26 1997-12-26 複素環化合物 Expired - Fee Related JP4189048B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Publications (3)

Publication Number Publication Date
JPH11193282A JPH11193282A (ja) 1999-07-21
JPH11193282A5 true JPH11193282A5 (fr) 2005-09-02
JP4189048B2 JP4189048B2 (ja) 2008-12-03

Family

ID=18490454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36788797A Expired - Fee Related JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Country Status (1)

Country Link
JP (1) JP4189048B2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157465B2 (en) 2001-04-17 2007-01-02 Dainippon Simitomo Pharma Co., Ltd. Adenine derivatives
AU2003271064B2 (en) 2002-09-27 2010-06-17 Dainippon Sumitomo Pharma Co., Ltd. Novel adenine compound and use thereof
EP1667694B1 (fr) * 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Ligands tlr7 destines au traitement du virus de l'hepatite c
WO2005092893A1 (fr) 2004-03-26 2005-10-06 Dainippon Sumitomo Pharma Co., Ltd. Compose 8-oxoadenine 9-substitue
ES2577514T3 (es) * 2005-08-22 2016-07-15 The Regents Of The University Of California Antagonistas de TLR
WO2007093901A1 (fr) 2006-02-17 2007-08-23 Pfizer Limited Dérivés de 3-déazapurine en tant que modulateurs de tlr7
EP2041135A4 (fr) 2006-07-05 2010-12-01 Astrazeneca Ab Dérivés de la 8-oxoadénine agissant comme modulateurs de tlr7
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
ES2552471T3 (es) 2007-02-07 2015-11-30 The Regents Of The University Of California Conjugados de agonistas de TLR sintéticos y usos de los mismos
EP2132209B8 (fr) 2007-03-19 2014-04-16 AstraZeneca AB Composés 8-oxo-adenine 9 substitué comme modulateurs du récepteur de type toll (tlr7)
EP2139894B1 (fr) 2007-03-19 2011-10-26 AstraZeneca AB Composés de 8 oxo-adenine 9 substitué comme modulateurs du récepteur de type toll (tlr7)
WO2008114819A1 (fr) 2007-03-20 2008-09-25 Dainippon Sumitomo Pharma Co., Ltd. Nouveau composé d'adénine
AR065784A1 (es) * 2007-03-20 2009-07-01 Dainippon Sumitomo Pharma Co Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
KR20100016289A (ko) 2007-05-08 2010-02-12 아스트라제네카 아베 면역-조정 특성의 이미다조퀴놀린
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
UY31531A1 (es) 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
WO2009091032A1 (fr) 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. Procédé de production d'un composé d'adénine
WO2010088924A1 (fr) 2009-02-06 2010-08-12 Telormedix Sa Compositions pharmaceutiques comprenant des imidazoquinolines (amines) et des dérivés de celles-ci appropriés pour une administration locale
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
CN102482233A (zh) 2009-05-21 2012-05-30 阿斯利康(瑞典)有限公司 新颖的嘧啶衍生物和它们在治疗癌症和其它疾病中的用途
US8962652B2 (en) 2009-10-22 2015-02-24 Gilead Sciences, Inc. Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
NZ603155A (en) 2010-04-30 2014-06-27 Telormedix Sa Phospholipid drug analogs
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
JP5978225B2 (ja) 2010-12-16 2016-08-24 大日本住友製薬株式会社 治療に有用なイミダゾ[4,5−c]キノリン−1−イル誘導体
ES2627433T3 (es) 2010-12-17 2017-07-28 Sumitomo Dainippon Pharma Co., Ltd. Derivados de purina
TWI619704B (zh) 2012-05-18 2018-04-01 大日本住友製藥股份有限公司 羧酸化合物
PL3294740T3 (pl) * 2015-05-08 2020-03-31 F. Hoffmann-La Roche Ag Nowe sulfonoimidoilopurynony i pochodne do leczenia i profilaktyki infekcji wirusowych
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
AU2017320742B2 (en) 2016-08-29 2021-08-05 F. Hoffmann-La Roche Ag 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
CN109715214B (zh) 2016-09-13 2022-03-04 豪夫迈·罗氏有限公司 Tlr7激动剂和hbv衣壳组装抑制剂的组合治疗
JP7328977B2 (ja) * 2018-02-12 2023-08-17 エフ. ホフマン-ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
RU2020131012A (ru) 2018-02-28 2022-03-28 Ф. Хоффманн-Ля Рош Аг 7-замещенные соединения сульфонимидоилпуринонов и их производные для лечения и профилактики рака печени

Similar Documents

Publication Publication Date Title
JPH11193282A5 (fr)
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
JP2005515255A5 (fr)
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
CA2436846A1 (fr) Imidazoquinolines a substitution thioether
WO2005056524A3 (fr) Agents therapeutiques pour traitement de la douleur
LU90956I2 (fr) Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique
CA2107014A1 (fr) Agent therapeutique pour la maladie de parkinson
CA2545427A1 (fr) Inhibiteurs selectifs de kinases
JP2008511633A5 (fr)
TNSN04213A1 (en) High drug load tablet
JP2001526218A5 (fr)
JP2002520316A5 (fr)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
DE60001586D1 (de) Diphenyl-piperidin derivate
JP2000159790A5 (fr)
CA2302568A1 (fr) Procede, compositions et trousses servant a augmenter la biodisponibilite orale d'agents pharmaceutiques
JPH10147529A5 (fr)
SE0102440D0 (sv) New compound
CA2440014A1 (fr) Derives de beta-carboline et leur utilisation pharmaceutique contre la depression et l'anxiete
WO1999033450A3 (fr) Agents therapeutiques
JP2002506864A5 (fr)
CA2461963A1 (fr) Amines cycliques
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom